Clinical Trial: PRO1160 for Advanced Solid and Liquid Tumors (PRO1160-001)
Study Status: Completed
Recruit Status: RECRUITING
Condition: Renal Cell Carcinoma
Study Type: INTERVENTIONAL
Official Title: Phase 1/2 Study of PRO1160 in Patients With Renal Cell Carcinoma (RCC), Nasopharyngeal Carcinoma (NPC), or Non-Hodgkin Lymphoma (NHL)
Brief Summary:
Brief Summary:This study will test the safety, including side effects, and determine the characteristics of a drug called PRO1160 in participants with solid tumors.Participants will have solid tumor or liquid cancer that has spread through the body (metastatic) or cannot be removed with surgery (unresectable).This Phase 1/2 study will have two parts.Part A of the study will find out how much and how frequently PRO1160 should be given to participants.Part B will use the dose and schedule found in Part A to…
Read more